Metabolic Pathways Overview: How Cells Organize Chemical Reactions

What Defines a Metabolic Pathway

A metabolic pathway is a series of chemical reactions in which each step is catalyzed by a specific enzyme. The starting molecule is transformed through a sequence of intermediates (metabolites) until a final product is generated. Pathways can be linear (like glycolysis, where glucose is converted step by step to pyruvate), cyclic (like the citric acid cycle, where the starting molecule oxaloacetate is regenerated at the end of each turn), or branched (where an intermediate feeds into multiple downstream routes).

Each pathway has at least one committed step, an essentially irreversible reaction that directs metabolites into that specific pathway. The enzyme catalyzing the committed step is typically the primary regulatory point, controlled by allosteric effectors, covalent modification, or changes in gene expression. By regulating just one or a few enzymes, the cell can control the flux through an entire pathway without needing to regulate every individual reaction.

Glycolysis

Glycolysis is a ten-step pathway in the cytoplasm that converts one molecule of glucose (six carbons) into two molecules of pyruvate (three carbons each), producing a net yield of 2 ATP and 2 NADH. It is present in virtually all living organisms, making it one of the most ancient metabolic pathways. Glycolysis does not require oxygen, allowing it to supply energy under both aerobic and anaerobic conditions.

The pathway is regulated at three irreversible steps. Hexokinase catalyzes the first step (phosphorylation of glucose) and is inhibited by its product, glucose-6-phosphate. Phosphofructokinase-1 (PFK-1) catalyzes the committed step and is the primary control point: it is activated by AMP and fructose-2,6-bisphosphate (signaling that energy or glucose is needed) and inhibited by ATP and citrate (signaling that energy is abundant). Pyruvate kinase catalyzes the last step and is activated by fructose-1,6-bisphosphate (feedforward activation) and inhibited by ATP and alanine.

The Citric Acid Cycle

The citric acid cycle (also called the Krebs cycle or TCA cycle) operates in the mitochondrial matrix and completes the oxidation of fuel molecules by processing acetyl-CoA. Each turn of the cycle condenses the two-carbon acetyl group with the four-carbon oxaloacetate to form citrate (six carbons), then releases two carbons as CO2 through a series of oxidation reactions, regenerating oxaloacetate.

Each turn produces 3 NADH, 1 FADH2, and 1 GTP (equivalent to ATP). Since each glucose yields two acetyl-CoA molecules, two turns of the cycle per glucose produce 6 NADH, 2 FADH2, and 2 GTP. The NADH and FADH2 carry their electrons to the electron transport chain, where the bulk of ATP is generated through oxidative phosphorylation.

The cycle is regulated at three points: citrate synthase (inhibited by ATP, NADH, and citrate), isocitrate dehydrogenase (activated by ADP, inhibited by ATP and NADH), and alpha-ketoglutarate dehydrogenase (inhibited by NADH and succinyl-CoA). The common theme is that high energy charge (abundant ATP and NADH) slows the cycle, while low energy charge accelerates it.

Beyond its catabolic role, the citric acid cycle provides intermediates for biosynthesis. Citrate is exported to the cytoplasm for fatty acid synthesis. Alpha-ketoglutarate and oxaloacetate are precursors for amino acid synthesis (glutamate and aspartate, respectively). Succinyl-CoA feeds into heme biosynthesis. This dual function makes the citric acid cycle amphibolic, serving both catabolic and anabolic needs.

The Pentose Phosphate Pathway

The pentose phosphate pathway (PPP) branches from glycolysis at glucose-6-phosphate and serves two purposes that glycolysis does not: producing NADPH for reductive biosynthesis and generating ribose-5-phosphate for nucleotide synthesis.

The oxidative phase of the PPP converts glucose-6-phosphate to ribulose-5-phosphate, producing 2 NADPH per glucose. NADPH is essential for fatty acid synthesis, cholesterol synthesis, steroid hormone production, and the regeneration of reduced glutathione, which protects cells from oxidative damage. The rate-limiting enzyme, glucose-6-phosphate dehydrogenase (G6PD), is inhibited by NADPH, linking pathway activity to the cell's need for reducing power.

The non-oxidative phase interconverts three-, four-, five-, six-, and seven-carbon sugars through transketolase and transaldolase reactions. When a cell needs more NADPH than ribose, the non-oxidative phase recycles the carbon skeletons back into glycolytic intermediates, allowing the oxidative phase to continue generating NADPH. When a cell needs more ribose than NADPH (as during rapid DNA replication), glucose-6-phosphate can be converted to ribose-5-phosphate through the non-oxidative phase alone, bypassing the oxidative phase entirely.

Beta-Oxidation and Fatty Acid Synthesis

Beta-oxidation breaks down fatty acids in the mitochondrial matrix through a repetitive four-step cycle. Each cycle shortens the fatty acid chain by two carbons, releasing one acetyl-CoA, one NADH, and one FADH2. The acetyl-CoA enters the citric acid cycle, and the electron carriers deliver electrons to the electron transport chain. Complete oxidation of the 16-carbon palmitate yields 106 ATP, reflecting the high energy density of fatty acids.

Fatty acid synthesis occurs in the cytoplasm and uses a different set of enzymes from beta-oxidation. The multi-enzyme complex fatty acid synthase builds fatty acid chains two carbons at a time from malonyl-CoA, using NADPH as the reducing agent. The separation of synthesis (cytoplasm, using NADPH) from oxidation (mitochondrial matrix, producing NADH and FADH2) allows both pathways to be regulated independently through different enzymes, different coenzymes, and different cellular compartments.

Gluconeogenesis

Gluconeogenesis synthesizes glucose from non-carbohydrate precursors, primarily lactate, glycerol, and glucogenic amino acids. It occurs mainly in the liver and, to a lesser extent, the kidneys. Gluconeogenesis is essential during fasting and prolonged exercise, when glycogen reserves have been depleted and the brain still requires a steady supply of blood glucose.

Gluconeogenesis largely reverses glycolysis but uses different enzymes at the three irreversible steps. Pyruvate carboxylase and phosphoenolpyruvate carboxykinase (PEPCK) bypass pyruvate kinase. Fructose-1,6-bisphosphatase bypasses PFK-1. Glucose-6-phosphatase bypasses hexokinase. Using different enzymes at these steps allows glycolysis and gluconeogenesis to be regulated independently, preventing a futile cycle where glucose is simultaneously broken down and synthesized.

Gluconeogenesis is promoted by glucagon and cortisol and inhibited by insulin. During fasting, glucagon stimulates PEPCK and fructose-1,6-bisphosphatase through gene expression changes, while simultaneously inhibiting PFK-1 by lowering fructose-2,6-bisphosphate levels. This reciprocal regulation ensures that the liver switches smoothly between glucose consumption (fed state) and glucose production (fasted state).

Pathway Interconnections

Metabolic pathways do not operate in isolation. They are interconnected through shared intermediates that serve as metabolic crossroads. Glucose-6-phosphate connects glycolysis, the pentose phosphate pathway, glycogen synthesis, and gluconeogenesis. Pyruvate links glycolysis to gluconeogenesis, the citric acid cycle (via acetyl-CoA), and amino acid metabolism (via transamination to alanine). Acetyl-CoA is the convergence point for carbohydrate, fat, and protein catabolism and the starting point for fatty acid synthesis, cholesterol synthesis, and ketone body production.

These interconnections allow cells to redirect metabolites according to their needs. A muscle cell exercising vigorously channels glucose through glycolysis for rapid ATP production. A liver cell during fasting runs gluconeogenesis to supply blood glucose while simultaneously oxidizing fatty acids for its own energy needs. An adipocyte after a meal converts excess glucose to fatty acids for storage. The same fundamental pathways operate in each case, but different regulatory signals determine which pathways are active and which are suppressed.